About this trial
This randomized controlled trial will compare the prophylactic effectiveness of low-dose intravenous ketamine and tramadol in preventing post-spinal anesthesia shivering in patients undergoing orthopedic surgery at Shaheed Mohtarma Benazir Bhutto Institute of Trauma (SMBBIT), Karachi,
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
* ASA I and II patients aged 18-60 years.
Both genders.
Patients undergoing orthopedic surgery under spinal anesthesia.
Disqualifiers
* Patient refusal.
ASA III and ASA IV.
Prolonged surgical procedures expected to be more than 90 minutes.
Patients who received blood transfusion or study drugs other than for the study purpose.
Trial design
Parallel
Treatments tested in this trial
Tramadol
DrugIntravenous tramadol 0.5 mg/kg will be administered immediately after spinal anesthesia for prevention of post-spinal anesthesia shivering.
Ketamin
DrugIntravenous ketamine 0.25 mg/kg will be administered immediately after spinal anesthesia for prevention of post-spinal anesthesia shivering.
Treatment groups
Trial outcomes
Primary outcomes
Incidence of post-spinal anesthesia shivering
Shivering will be assessed after spinal anesthesia and the occurrence of post-spinal anesthesia shivering will be recorded.
Secondary outcomes
Severity of post-spinal anesthesia shivering
Severity of post-spinal anesthesia shivering will be assessed and recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: